Combination of Immune Checkpoint Inhibitors and Radiotherapy for Advanced Non-Small-Cell Lung Cancer and Prostate Cancer: A Meta-Analysis.
Zexi XuJia FengYi Ming WengYao JinMin PengPublished in: Journal of oncology (2021)
The combination of ICI and RT was associated with improved OS, PFS, and DCR. Patients under 65 years will be the dominant beneficiaries. However, the incidence of dyspnea and pneumonia of grade 3 or higher also increased, which deserves our vigilance.
Keyphrases
- advanced non small cell lung cancer
- prostate cancer
- end stage renal disease
- epidermal growth factor receptor
- newly diagnosed
- chronic kidney disease
- radical prostatectomy
- radiation therapy
- prognostic factors
- peritoneal dialysis
- risk factors
- squamous cell carcinoma
- locally advanced
- palliative care
- patient reported outcomes
- tyrosine kinase
- community acquired pneumonia
- extracorporeal membrane oxygenation